Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
approved crawled time : 14:20 save search
Franchise Group Stockholders Approve Proposed Acquisition by Consortium Led by Management Group
Published: 2023-08-17 (Crawled : 14:20) - globenewswire.com
FRG | $29.88 0.1% 0.1% 0
|
Commercial Services
|
| O: 0.54%
H: 0.44%
C: 0.03%
management group acquisition
J&J Snags FDA Approval for Second Multiple Myeloma Bispecific Antibody
Published: 2023-08-10 (Crawled : 14:20) - biospace.com/
JNJ | News | $150.09 0.65% 3.9M
|
Health Technology
|
| O: 0.75%
H: 1.13%
C: -1.05%
fda antibody approval
FDA GRANTS FULL APPROVAL FOR BLINCYTO® (BLINATUMOMAB) TO TREAT MINIMAL RESIDUAL DISEASE-POSITIVE B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA
Published: 2023-06-21 (Crawled : 14:20) - biospace.com/
BGNE | $138.615 5.86% 110K
|
Health Technology
|
| O: -0.8%
H: 0.36%
C: -2.33%
AMGN | News | $273.38 0.54% 790K
|
Health Technology
|
| O: -0.18%
H: 0.8%
C: -0.5%
blincyto fda approval treat grants leukemia
Zynex Receives FDA Clearance of CM-1600 Monitor for Improved Blood and Fluid Management
Published: 2023-06-20 (Crawled : 14:20) - biospace.com/
ZYXI | $11.2 0.54% 61K
|
Health Technology
|
| O: 0.73%
H: 2.06%
C: 0.93%
cm-1600 fda management blood clearance
PERRIGO ANNOUNCES U.S. FDA APPROVAL FOR NICOTINE COATED MINT LOZENGE
Published: 2023-05-16 (Crawled : 14:20) - biospace.com/
PRGO | $30.475 1.38% 360K
|
Health Technology
|
| O: -0.56%
H: 0.06%
C: -3.53%
fda approval
FDA Approves Fabry Disease Treatment from Chiesi, Protalix
Published: 2023-05-10 (Crawled : 14:20) - biospace.com/
SNY | News | $47.85 1.49% 920K
|
Health Technology
|
| O: -1.75%
H: 0.0%
C: 0.0%
fda disease treatment
DUPIXENT (dupilumab injection) is now approved in Canada for the treatment of adult and adolescent patients (12+) with Eosinophilic Esophagitis
Published: 2023-05-04 (Crawled : 14:20) - biospace.com/
SNY | News | $47.85 1.49% 920K
|
Health Technology
|
| O: 1.56%
H: 0.0%
C: 0.0%
approved dupixent treatment canada
Immutep Receives Approval to Initiate INSIGHT-005 Trial Evaluating Eftilagimod Alpha and Anti-PD-L1 Therapy BAVENCIO®
Published: 2023-05-01 (Crawled : 14:20) - globenewswire.com
IMMP | $2.49 7.33% 45K
|
Health Technology
|
| O: 1.52%
H: 0.9%
C: 0.9%
sight-005 bavencio approval trial therapy
GBT’s CIP Patent Application of 3D, Multiplanar Photonic Microchips Was Approved for Fast Track
Published: 2023-05-01 (Crawled : 14:20) - globenewswire.com
GTCH | $0.0001 0.0% 14M
|
Information
|
| O: 0.0%
H: 11.11%
C: 0.0%
patent approved application
Bright Green Announces Historic Federal Registration and License Approval from the U.S. Drug Enforcement Administration Confirming Bright Green as a Bulk Manufacturer of Cannabis
Published: 2023-05-01 (Crawled : 14:20) - globenewswire.com
BGXX | $0.2 0.96% 220K
|
|
| O: 4.83%
H: 19.08%
C: 1.97%
cannabis drug license approval
Libtayo (cemiplimab) in Combination with Chemotherapy now approved in Canada for the First-line Treatment of Advanced Non-small Cell Lung Cancer
Published: 2023-05-01 (Crawled : 14:20) - biospace.com/
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: 4.08%
H: 0.0%
C: 0.0%
SNY | News | $47.85 1.49% 920K
|
Health Technology
|
| O: -1.21%
H: 0.0%
C: 0.0%
lung approved cancer cell treatment libtayo canada
Vaxart Stockholders Approve Proxy Proposals 2, 3 and 4
Published: 2022-08-05 (Crawled : 14:20) - globenewswire.com
VXRT | News | $0.7744 1.56% 350K
|
Health Technology
|
| O: -1.53%
H: 7.53%
C: 6.75%
Dream Homes & Development Corp. secures Significant Funding Package for approved 70-Unit Berkeley Terrace Townhome Development and files 10K Annual Report for 2022
Published: 2023-04-17 (Crawled : 14:20) - globenewswire.com
DREM | $0.0181 313.98% 48K
|
| Email alert
Add to watchlist
report approved homes funding
CNS Pharmaceuticals Receives Approval from Competent Authority and Central Ethics Committee in Italy for Potentially Pivotal Global Trial Evaluating Berubicin for the Treatment of GBM
Published: 2023-04-06 (Crawled : 14:20) - biospace.com/
RETA | $172.36 0.02% 0.03% 0
|
Health Technology
|
| O: 0.79%
H: 0.86%
C: 0.6%
CNSP | News | $0.201 0.95% 61K
|
Health Technology
|
| O: 53.58%
H: 6.02%
C: -43.6%
approval berubicin treatment pharmaceuticals global trial
Scilex Holding Company Announces Financing of up to $25 Million to Enhance Commercialization of Three FDA Approved Non-Opioid Pain Management Products
Published: 2023-03-21 (Crawled : 14:20) - biospace.com/
SCLX | $1.01 6.16% 250K
|
|
| O: -0.38%
H: 6.19%
C: 3.92%
SRNE | $0.015 140K
|
Health Technology
|
| O: 0.78%
H: 7.24%
C: 5.23%
fda management approved commercialization
Goal Acquisitions Corp. Announces Shareholder Approval to Extend … – GlobeNewswire
Published: 2023-02-13 (Crawled : 14:20) - spacfeed.com
PUCK | $10.8 1.64% 2.4K
|
|
| O: -0.05%
H: 0.1%
C: 0.1%
acquisitions approval
Goal Acquisitions Corp. Announces Shareholder Approval to Extend Period to Consummate the Proposed Business Combination with Digital Virgo – Yahoo Finance
Published: 2023-02-13 (Crawled : 14:20) - spacfeed.com
PUCK | $10.8 1.64% 2.4K
|
|
| O: -0.05%
H: 0.1%
C: 0.1%
acquisitions approval
Pierre Fabre to Commercialize and Distribute the First Approved Allogeneic T-cell Immunotherapy in Europe Following Transfer of the European Commission Marketing Authorization of EBVALLO™ (tabelecleucel)
Published: 2023-02-08 (Crawled : 14:20) - biospace.com/
ATRA | $0.7002 0.4% 230K
|
Health Technology
|
| O: 0.0%
H: 0.89%
C: -7.69%
europe immunotherapy transfer t-cell approved authorization
NeuroSense Receives Approval in Germany to Enroll Patients in its Phase 2b ALS Trial
Published: 2023-02-08 (Crawled : 14:20) - prnewswire.com
NRSN | News | $1.35 68K
|
|
| O: -0.65%
H: 23.68%
C: 0.0%
enroll als trial approval germany
ContraPest® Approved for General Use in New York State
Published: 2023-02-06 (Crawled : 14:20) - prnewswire.com
SNES | $0.7433 19K
|
Health Technology
|
| O: 5.23%
H: 52.28%
C: 0.45%
contrapest state approved
Gainers vs Losers
| 87% | 13% |
Top 10 Gainers
MTTR | News M | $4.64 166.67% 18M
|
AGBA | $2.61 108.8% 41M
|
Finance
CZOO | $9.32 86.77% 18M
|
EDBL | News | $6.7 78.19% 1.7M
|
OPRT | News | $3.37 49.78% 8.9M
|
Finance
MTC | $2.14 37.18% 4.9M
|
Technology Services
VNRX | $0.8 33.33% 2.9M
|
Health Technology
MLEC | $1.79 27.86% 2.6M
|
n/a
PALI | $6.29 27.59% 22M
|
Manufacturing
MCRB | $0.7902 26.51% 6.9M
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.